drugset / Trial / NCT07347860
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
Phase 0
Recruiting
12 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ITabMed Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study was to evaluate the safety and tolerability of A-319 in patients with active rheumatoid arthritis.
Timeline
- Start
- 2026-01-08
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | A-319 | Monoclonal antibody | — | Subcutaneous |